Source link : https://newshealth.biz/health-news/drug-fights-glp-1-muscle-loss-unapproved-retatrutide-prescriptions-protein-swap/
Investigational apitegromab — a selective myostatin activation inhibitor — effectively preserved lean mass when combined with tirzepatide (Zepbound) in a randomized phase II trial, suggesting it could help fight “Ozempic butt.” (Nature Medicine, BBC News) The FDA hasn’t yet reviewed retatrutide for safety and effectiveness, but doctors are prescribing the investigational weight-loss drug anyhow. (CBS […]
The post Drug Fights GLP-1 Muscle Loss; Unapproved Retatrutide Prescriptions; Protein Swap first appeared on News Health.
—-
Author : News Health
Publish date : 2026-06-09 18:57:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8